AFP and hepatocellular carcinoma: Using an AFP cut-off of 11.2 μg/L, sensitivity reached 82.9% and specificity 65.5%, indicating that AFP correctly classified over 80% of HCC outcomes while excluding nearly two-thirds of non-cases.